Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combined modality therapy for primary CNS lymphoma.

L M DeAngelis1, J Yahalom, H T Thaler

  • 1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|April 1, 1992
PubMed
Summary

Combining chemotherapy with cranial radiotherapy significantly improves disease-free survival for primary CNS lymphoma (PCNSL) patients. This combined approach offers better outcomes than radiotherapy alone for initial treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study.

ESMO open·2021
Same author

Recommendations for the clinical management of the elderly patient with malignant lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas.

Journal of neuro-oncology·2017
Same author

Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG).

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Alternatives in the Management of Gastric Lymphoma.

Leukemia & lymphoma·2016

Area of Science:

  • Neuro-oncology
  • Clinical oncology
  • Radiation oncology

Background:

  • Primary CNS lymphoma (PCNSL) is increasingly diagnosed in immunocompetent individuals.
  • Conventional treatment with radiotherapy and corticosteroids yields limited survival rates.
  • Chemotherapy has shown efficacy in treating recurrent PCNSL.

Purpose of the Study:

  • To evaluate the efficacy of a combined modality treatment protocol for initial therapy of non-AIDS primary CNS lymphoma.
  • To compare outcomes of combined chemotherapy and radiotherapy with radiotherapy alone.

Main Methods:

  • Thirty-one patients received combined modality therapy: systemic and intra-Ommaya methotrexate, followed by whole-brain radiotherapy and high-dose cytarabine.
  • Sixteen patients received radiotherapy alone.

Related Experiment Videos

  • Follow-up extended through April 1, 1991.

    • Main Results:

    • The combined modality group (Group A) demonstrated a significantly prolonged time to recurrence (median 41 months) compared to the radiotherapy-only group (Group R, median 10 months).
    • Median survival was doubled in Group A (42.5 months) versus Group R (21.7 months), though not statistically significant due to sample size.
    • Systemic chemotherapy for recurrent PCNSL in Group R patients improved their survival.

    Conclusions:

    • The addition of chemotherapy to cranial radiotherapy significantly enhances disease-free survival in primary CNS lymphoma.
    • Combined modality therapy should be considered for all newly diagnosed non-AIDS PCNSL patients.
    • This approach contributes to improved overall survival for primary CNS lymphoma.